favynd
boehringer ingelheim international gmbh - tiotropio bromidas - įkvepiamieji milteliai (kietosios kapsulės) - 18 µg - tiotropium bromide
spiriva respimat
boehringer ingelheim international gmbh - tiotropis - įkvepiamasis tirpalas - 2,5 µg/išpurškime - tiotropium bromide
atrovent n
lex ano, uab - ipratropio bromidas - suslėgtasis įkvepiamasis tirpalas - 20 µg/dozėje - ipratropium bromide
ontipria
zentiva k.s. - tiotropis - įkvepiamieji milteliai (kietosios kapsulės) - 18 µg - tiotropium bromide
atrovent n
nenurodyta - ipratropio bromidas - suslėgtasis įkvepiamasis tirpalas - 20 µg/dozėje - ipratropium bromide
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - imuninės serumai ir imunoglobulinai, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.